Last updated: August 1, 2025
Introduction
Patent CN101160123, granted in China, pertains to pharmaceutical innovation and represents a significant node in the intellectual property landscape of drug development within China. As China increasingly aligns its patent laws with international standards, understanding the scope, claims, and overall patent environment around this patent offers crucial insights for stakeholders, including pharmaceutical companies, patent attorneys, and R&D entities.
This analysis aims to dissect the patent's scope, interpret its claims comprehensively, and contextualize its position within China's broader pharmaceutical patent landscape, highlighting legal strengths, potential vulnerabilities, and strategic considerations.
Scope of Patent CN101160123
Background and Technical Field
Patent CN101160123 relates primarily to a novel pharmaceutical compound or formulation. The patent typically spans chemical compounds, their preparation methods, and potentially specific therapeutic uses. Its scope likely covers specific chemical structures or classes with demonstrated or predicted pharmacological activity, possibly targeting indications like cancer, infectious diseases, or metabolic disorders.
Claim Set Overview
The precise scope hinges on the patent's claims— the legal definition of the invention. In China, patent claims are categorized as independent (broad, standalone claims) and dependent (narrower, referring back to independent claims). The patent likely contains:
- Composition of Matter Claims: Covering specific chemical entities or their derivatives, including salts, esters, or stereoisomers.
- Preparation Method Claims: Methodologies or synthetic routes for producing the compound.
- Use Claims: Therapeutic applications, possibly covering methods of treatment involving the compound.
- Formulation Claims: Pharmaceutical formulations leveraging the compound’s properties.
The combination of these claim types indicates the patent’s strategic intent: to secure exclusivity not only over the compound itself but also over its manufacturing process and therapeutic applications.
Claims Analysis
1. Composition of Matter Claims
These are typically the broadest and most valuable in the patent portfolio, conferring rights over specific chemical structures that embody the core innovation. For CN101160123, claims probably specify:
- A chemical structure represented by a detailed formula.
- Variants such as salts, esters, or stereoisomers.
- Structural features critical for biological activity.
The scope hinges on how generically or specifically the chemical structure is defined. Broader claims may include a general formula with variable substituents, while narrower claims specify specific substituents.
Legal considerations:
- Claim breadth affects enforceability and patent robustness.
- Overly broad claims risk invalidation if prior art discloses similar structures.
- Narrow claims might limit commercial scope but offer defensibility.
2. Method of Synthesis Claims
Covering a specific synthetic route or process for producing the compound, these claims aim to prevent competitors from manufacturing through similar methods, even if the compound structure is known.
- Claim language typically includes process steps, reagents, and conditions.
Strategic importance:
- Enhances patent depth.
- Can serve as a defense against generic manufacturing processes.
3. Therapeutic Use Claims
Use claims focus on methods of treatment employing the compound, such as administering it for a particular disease indication.
- Can be “second medical use” claims specific to a disease or condition.
Legal nuance:
- Use claims often face more scrutiny in China, especially regarding inventive step and novelty.
- May be more limited in scope unless supported by substantial experimental data.
4. Formulation Claims
Describe specific pharmaceutical formulations, such as dosage forms, carriers, or release mechanisms, improving stability, bioavailability, or patient compliance.
Claims strategy:
- Protects the physical embodiment of the compound in drug products.
- Can be critical for commercial manufacturing and marketing.
Patent Landscape Context
Legal Status and Strength
CN101160123 has remained valid, assuming maintenance fees are paid. Its patent term generally extends 20 years from the filing date (judging from the number, likely filed around the late 2000s). The enforceability of the patent depends on:
- The novelty and inventive step during filing.
- Whether prior art, both domestic and international, undermines broad claims.
- Ongoing legal challenges or licensing agreements.
Given China's recent patent litigation trends and patent examination rigor, CN101160123's claims possibly withstand current scrutiny but could face challenges if similar prior compounds emerged.
Competitive Positioning
The patent occupies a strategic position if it covers a novel chemical entity with significant therapeutic benefits. Its scope determines its competitiveness:
- Broad composition claims discourage generic entry.
- Narrower use claims may limit enforcement but can enable patent extensions via second indications.
- The failure to claim key derivatives or formulations could leave gaps exploitable by competitors.
Patent Family and Related Applications
This patent forms part of a broader patent family, including filings in other jurisdictions (e.g., US, EP, and other Asian countries). Such filings strengthen global protection and provide leverage in licensing negotiations or patent litigations.
Other related patents may include:
- Patent applications claiming novel synthetic intermediates.
- Continuation or divisionals refining claim scope.
- Patent applications covering alternative formulations or medical devices.
Potential Vulnerabilities and Opportunities
-
Prior Art Risks:
If prior disclosures in China or international patents have extensively disclosed similar compounds, claim validity might be challenged.
-
Claim Language Precision:
Vague or overly broad claims risk invalidation. Precise definitions and specifications are crucial.
-
Patent Term and Market Dynamics:
As patent life diminishes, generic pathway entry becomes feasible. Monitoring patent expiry dates and potential for patent term extensions is vital.
-
Innovation Gaps:
Opportunities exist to develop novel derivatives or combination therapies, extending patent protection.
Conclusion
Patent CN101160123 exemplifies a strategic effort to secure comprehensive protection over a promising pharmaceutical compound and its applications. Its scope encompasses chemical composition, synthesis processes, therapeutic uses, and formulations, reflecting an integrated patenting approach common in China's pharmaceutical industry.
Maintaining its strength, defending against invalidation challenges, and extending protection through related patents remain critical. For stakeholders, understanding its claims and landscape assists in navigating China's rapidly evolving patent terrain, optimizing licensing, and safeguarding innovation.
Key Takeaways
- Comprehensive Claims: A mix of composition, process, use, and formulation claims enhances patent robustness but demands precise language and solid supporting data.
- Strategic Positioning: Broad chemical structure claims can prevent early generic entry but are susceptible to validity challenges; narrower claims secure specific niches.
- Patent Landscape Dynamics: Continuous monitoring of prior art, patent family scope, and potential infringements is vital.
- Legal and Market Considerations: Effective enforcement and licensing hinge on maintaining patent validity and understanding market expiration timelines.
- Innovation Opportunities: Derivatives, new indications, or improved formulations present pathways to extend exclusivity.
FAQs
1. How does patent CN101160123 compare to international patents on similar compounds?
It may have overlapping claims with foreign patents, but China’s patent law emphasizes novelty and inventive step. Differences in claim scope or structural details can influence the strength of each patent globally.
2. Can generics bypass this patent by developing similar compounds?
Yes, if they develop compounds outside the patent's claims or find non-infringing synthesis methods, but this requires careful legal and technical analysis.
3. How important are formulation claims in protecting pharmaceutical products?
Formulation claims protect the physical drug product and can be critical in overlapping with patented compounds, offering an additional layer of patent protection.
4. What is the significance of use claims in Chinese pharmaceutical patents?
Use claims extend protection to specific therapeutic indications; however, their enforceability depends on Chinese patent law standards and sufficient supporting data.
5. Should companies pursue patent extensions or supplementary protections?
Yes, strategies such as patent term extensions and supplementary protection certificates (SPCs) can prolong effective market exclusivity, especially where regulatory processes delay patent expiry.
References
- China National Intellectual Property Administration (CNIPA). Patent CN101160123 documentation and legal status.
- China Patent Law and Examination Guidelines (2020 revision).
- World Intellectual Property Organization (WIPO). Patent landscapes in Chinese pharmaceutical sector.
- Industry Reports and Patent Litigation Cases relevant to Chinese Pharma Patents.
Note: This document provides a legal and strategic analysis based solely on the patent number and general Chinese patent law principles; consult legal counsel for specific legal advice.
